Therapeutic antibodies

monospecific antibody that is made by identical immune cells that are all clones of a unique parent cell

type of immunoglobulin

injection of a specific mixture of antibodies to treat a number of health conditions

Burosumab, sold under the brand name Crysvita, is a human monoclonal antibody medication approved 2018 for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia.

A plantibody is an antibody produced by plants that have been genetically engineered with animal DNA encoding a specific human antibody known to neutralize a particular pathogen or toxin. The transgenic plants produce antibodies similar to their human counterparts, and following purification, plantibodies can be administered therapeutically to acutely ill patients or prophylactically to at-risk individuals (such as healthcare workers). The term plantibody was trademarked by the company Biolex.